Presentation is loading. Please wait.

Presentation is loading. Please wait.

Atrial Fibrillation, AntiCoagulation

Similar presentations


Presentation on theme: "Atrial Fibrillation, AntiCoagulation"— Presentation transcript:

1 Atrial Fibrillation, AntiCoagulation
Mahesh Pauriah Consultant Cardiologist & Cardiac Electro- physiologist

2 Case 1 74 year old lady Routine visit
Irregularly irregular pulse on examination Mild SOB on moderate exertion PMH: Hypertension Meds: valsartan Allergies Nil Examination: HR 115 bpm , BP 135/76 mmHg Heart sounds normal – chest clear

3

4

5 Bloods: 2 weeks ago FBC: Hb 12.5 mg/dl, Normal Renal function TFTs Normal What would you do? – patient feels well

6 Rate control Ant coagulate

7 Rate control : beta blocker – Bisoprolol 2
Rate control : beta blocker – Bisoprolol 2.5 mg BD , calcium channel blocker if asthma +/-Digoxin Bisoprolol 2.5 mg BD , increase to 3.75 mg BD, then 5 mg DB- then change to once a day meds Aim for a resting HR < 90 bpm

8 Anticoagulate : CHADSVasc Score
Warfarin Xorelto , Dabigatran, Apixiban ? DC Cardioversion

9 Dental Issues Endoscopy / Colonoscopy Surgery PCI- antiplatelets

10 6 Months later – complains of increasing SOB,
Bilateral ankle oedema Orthopnoea/ PND ECG: Rate control AF ECHO – severe LV Impairment.

11 Heart Failure Meds- ACE inhibitor Diuretics Spironolactone. Optimise meds

12 GI Bleeding

13 Atrial Fibrillation AF is very common More common in men than women.
AF rates in the population increases with increasing age. lifetime risk of atrial fibrillation has been estimated to be 1 in 5 of the population

14 Background

15 Change with Time

16 Types of Atrial Fibrillation
(1) Paroxysmal AF is self-terminating, usually within 48 h (2) Persistent AF: defined if AF episode either lasts longer than 7 days or requires termination by cardioversion, either with drugs or by direct current cardioversion (DCC) (3) Long-standing persistent AF : if AF is present for ≥1 year

17 Natural History

18 Strategies to Treat AF ANTICOAGULATION RATE vs RHYTHM CONTROL

19 Risk of Stroke

20

21 Left Atrial Appendage Thrombus

22 Risk of Stroke Determine The Risk of Stroke
Risk of Bleeding with anticoagulation CHADS Score or CHADSVASC Score

23

24 CHADSVASC and Risk of Stroke

25

26 Anticoagulation Warfarin – Keep INR between 2-3 NOAC Dabigatran
Rivoraxaban Apixiban Endoxaban

27 Tachy-Brady Syndrome

28

29 Symptomatic or poor heart rate control/ Intolerant to Meds

30 Anticoagulation Based on ChadsVasc Score Rate Vs Rhythm Control
For asymptomatic Patients rate control as good as rhythm control Aim for resting HR < 90 bpm and < 110 bpm on exercise For symptomatic patients- try to keep sinus rhythm Trial of cardioversion for most patients

31 Rate Control Beta Blockers
Bisoprolol – start small and increase dose Digoxin – may need to dose a level 6 nours post dose Addition of Digoxin to Beta Blockers may reduce the dose of Beta Blockers required Calcium channel Blockers- eg Diltiazem/ Verapamil- use with caution- Heart Failure

32 Case Study 2 35 year old man Marathon Runner
Episodes of Irregular Irregular Heart rhythm Lasts for 4-6 hours Bloods Normal ECG Normal Echo Normal Several Holter monitor Normal

33 Modern Technology

34 ALIVECOR

35

36

37 Example of Transmission

38 Diagnosis Paroxysmal Atrial Fibrillation Treatment Medical Ablation

39 Medical Management of AF
Reassurance- this is not not going to lead to death/heart attack Refrain from Binge Drinking Relax “Ride it out” Seek help if unwell Pill in the pocket Flecainide & Beta Blockers

40 Flecainide Excellent Drug However, can lead to arrhythmia
Make sure ECG Normal ECHO Normal No Evidence of Coronary Artery Disease Danger with Atrial Flutter and Flecainide alone

41 Atrial Fibrillation Ablation
For Troublesome symptomatic AF

42 Atrial Fibrillation Ablation

43

44 Success Rates Success rates variable Works well with Paroxysmal AF
Redo rates Less well with Persistent Poor with Longstanding Persistent AF

45 Complications Stroke- 1:200
Use Heparin intra-procedural Groin Haematoma – requiring Intervention 1:200 Tamponade 1:200 Emergency Operation or Death 1: 1000

46 Stroke in Young Man 40 year old man PMH: Nil Meds : Nil Allergies: Nil
Admitted with Stroke Good Recovery

47 Investigations Bloods Normal , Including vasculitis Screen
MRI Confirms CVA ECG ECHO Bubble Echo Holter Monitor – Normal

48 Bubble Echo

49 What Next

50

51 How to Implant

52 Automatic Transmission

53 Unrelated Case 65 year old man with sudden LOC a few weeks ago
Seen in AE – discharged Seen at MPH – ECG/Echo /ETT Normal Holter Normal Loop Recorder

54

55

56 Plan: Bloods/ TFTs Anticoagulation

57 Anticoagulate Holter monitor – to ascertain rate control DC Cardioversion -3 weeks before and 4 weeks afterwards

58

59 Case 3 84 year old Dizzy spells Bisoprolol 10 mg OD Diltiazem
PMH: Hypertension Meds: As above

60

61 Admit Stop all rate limiting drugs Anticoagulation Monitor – BP stable No temporary wire HR settled mild tachycardia after 4 days. Started on Bisoprolol 1.25 mg OD- HOME no pacemaker . Well 9 months later

62 Case 4 76 year old man Previously well January – fell
Subdural Haematoma 2 weeks in CUH Treated Conservatively Asprin Stopped

63 PMHX : Hypertension Discharged 2 weeks later Change in Personality Dizzy,

64 Recurrent admissions to Hospital since then – repeat CT bleed getting better
Noted to have an irregular pulse Holter : Episodes of atrial Flutter

65 ECG

66 Discussed with Neurosurgery
Admitted to Hospital Rate controlled Bisoprolol / Digoxin – Discussed with Neurosurgery Risk of bleeding high Repeat Scan in 2 weeks CHADSVasc Score 3:

67

68 Atrial flutter Ablation

69 Atrial Flutter

70 Repeat CT Scan today – SDH almost resolved
Can go on a NOAC

71 Case 5 78 year old gentleman Previous Bowel cancer
Treated with surgery and radiation – 5 years ago 6 months history of SOB and palpitations

72 Examination : Gross heart failure
Treated with diuretics Rate control : Digoxin and beta blockers Ramipril 5 mg BD Spironolactone Warfarin Echo : EF of about 20% [ normal > 50%]

73

74 Much better rate control Discharged Home
Heart rate settled Much better rate control Discharged Home Medications on Discharge Warfarin Bisoprolol 10 mg Digoxin 125 mcg Ramipril 2.5 mg OD Spironolactone 25 mg OD

75 Medications Optimised
Warfarin Ramipril 5 mg BD Bisoprolol 10 mg Digoxin

76 3 months later NYHA 3 On Optimal Meds
Anti coagulated- Recurrent PR Bleeds LBBB and rate controlled AF

77 Treatment options for patients with chronic symptomatic systolic heart failure (NYHA functional class II–IV). Treatment options for patients with chronic symptomatic systolic heart failure (NYHA functional class II–IV). Authors/Task Force Members et al. Eur Heart J 2012;33: © The European Society of Cardiology All rights reserved. For permissions please

78

79 Biventricular Pacemaker

80 Amiodarone – well loaded Cardioverted EF almost normal NYHA 1
Almost back to normal . Recurrent bleeds requiring transfusion

81 Changed warfarin to Apixiban 5 mg BD
Still PR Bleed- requiring transfusion

82

83 Lower dose of NOAC- bleed SR for 6 months- stop all anticoagulants
Declined watchman Lower dose of NOAC- bleed SR for 6 months- stop all anticoagulants Atrial Fibrillation alarm

84 Cardiac Electrophysiology, Arrhythmia & Heart Failure

85 Drugs for Heart Failure

86 Heart Failure

87 THANK YOU


Download ppt "Atrial Fibrillation, AntiCoagulation"

Similar presentations


Ads by Google